Focus on Paediatric Restrictive Cardiomyopathy: Frequently Asked Questions

Diagnostics (Basel). 2023 Dec 14;13(24):3666. doi: 10.3390/diagnostics13243666.

Abstract

Restrictive cardiomyopathy (RCM) is characterized by restrictive ventricular pathophysiology determined by increased myocardial stiffness. While suspicion of RCM is initially raised by clinical evaluation and supported by electrocardiographic and echocardiographic findings, invasive hemodynamic evaluation is often required for diagnosis and management of patients during follow-up. RCM is commonly associated with a poor prognosis and a high incidence of heart failure, and PH is reported in paediatric patients with RCM. Currently, only a few therapies are available for specific RCM aetiologies. Early referral to centres for advanced heart failure treatment is often necessary. The aim of this review is to address questions frequently asked when facing paediatric patients with RCM, including issues related to aetiologies, clinical presentation, diagnostic process and prognosis.

Keywords: paediatric; restrictive cardiomyopathy.

Publication types

  • Review

Grants and funding

This research received no external funding.